Showing posts with label chronic obstructive pulmonary disease. Show all posts
Showing posts with label chronic obstructive pulmonary disease. Show all posts

Monday, October 28, 2013

Yoga can "significantly" improve COPD symptoms, say researchers

Photo: Ambro/freedigitalphotos.net
Patients with COPD who practice yoga can improve their lung function, according to a study by researchers at the All India Institute of Medical Sciences. The study, found that lung function, shortness of breath, and inflammation all showed significant improvement after patients completed 12 weeks of training.

An estimated 24 million Americans may have COPD, which includes chronic bronchitis, emphysema, or both. Patients with COPD have trouble pushing used air out of their lungs, making it difficult to take in healthy new air. Although there is no cure for COPD, a patient’s quality of life can be improved by controlling symptoms, such as shortness of breath. COPD, most commonly caused by cigarette smoking, affects both men and women, and often, symptoms are seen in people in their 40s.

“COPD is a systemic inflammatory disease that causes difficulty breathing,” said study presenter Randeep Guleria, MD, professor and head, department of pulmonary medicine and sleep disorders. “We investigated to see whether simple, structured yoga training affects the level of inflammation, shortness of breath, and quality of life in patients with stable COPD.”

The study included 29 stable patients with COPD who received yoga training in a format that included the use of physical postures (asanas), breathing techniques (pranayama), cleansing techniques, (kriyas), meditation, and a relaxation technique (shavasan) for 1 hour, twice a week, for 4 weeks. Following the 4-week period, patients were trained for 1 hour every 2 weeks, with the remaining sessions completed at home. Patients were evaluated on assessment of lung function, breathing, quality of life, and inflammation status. A repeat assessment was done at the end of the 12-week training session. All parameters showed significant improvement at the end of the 12-week period.

“We found that yoga can be a simple, cost-effective method that can help improve quality of life in patients with COPD,” stated Dr. Guleria.

---------------------------------------------------------------
Cleaner indoor air quality can also improve COPD symptoms. AllerAir air purifiers offer medical-grade filtration in a robust, unit designed to run constantly for years with little maintenance. Our air cleaners recommend for COPD patients include medical-grade HEPA filters for particles and activated carbon filters to remove the airborne chemicals and odors that other air cleaners leave behind. Connect with us to learn more www.allerair.com.

Friday, September 06, 2013

Many COPD patients feel outlook is bleak; Researchers call for more education

(Source: Medwire News)

Researchers behind a global survey of chronic obstructive pulmonary disease (COPD) patients say that more must be done to educate patients about the disease and what to do during exacerbations.

The team, led by Neil Barnes from the London Chest Hospital, UK, surveyed patients from 14 countries and found that many seemed to have low expectations around disease control and were unaware of the importance of responding quickly to exacerbations.

Furthermore, the study highlighted the impact of COPD on patient quality of life, with many reporting they took a limited outlook on the future and feared the illness would curtail their life expectancy.

“By highlighting the fears and concerns of COPD patients, many of whom are of working age with financial and familial responsibilities, the survey draws attention to the need for better patient education regarding the severity of the disease, the importance of prompt treatment of exacerbations, and the treatment and lifestyle options available,” Barnes and team write in BMC Pulmonary Medicine.

Their study involved survey responses from 2000 patients with COPD, chronic bronchitis, and/or emphysema, who were categorized according to Medical Research Council (MRC) breathlessness score: 1231 (62%) were grades 1 or 2 and 769 (38%) were grades 3–5.

The team found that despite heavy healthcare use during the preceding 12 months, 69% of patients thought that their COPD was well-controlled.

“This type of mismatch is not unusual, and has been widely reported in studies of both COPD and asthma patients, suggesting low levels of expectation,” the authors comment.

Overall, 62% of patients in MRC 1 or 2 grades and 80% of patients in MRC grades 3 to 5 had experienced an exacerbation in the previous 12 months, with 52% of patients in the latter group requiring hospitalization.

However, 27% of patients did not contact their healthcare service during exacerbation, taking actions such as cutting down on smoking, resting, or increasing medication dosage instead. And, less than 60% said that they would take immediate action in response to an exacerbation.

Patients reported that COPD and exacerbations affected their quality of life and their ability to commit to future events, with 77% worried about their long-term health. Additionally, 38% of MRC 1 and 2 patients said they feared premature death due to COPD, as did 59% of MRC 3 to 5 patients.

---------------------------------------------------------
Are you suffering from a respiratory condition? Improving your indoor air quality can be an integral part of your treatment plan. AllerAir air purifiers remove 99.97% of airborne dust, particles and the chemicals and odors that other air cleaners leave behind. Connect with us to learn more about air purifiers for COPD sufferers at www.allerair.com.


Friday, September 21, 2012

Researchers find genetic link between smoking, COPD

University of Iowa researchers have found what they believe is the first link between smoking and decreased expression of a new class of noncoding RNAs (microRNAs) in smokers’ immune cells.

“Only 20 percent of smokers get chronic obstructive pulmonary disease (COPD), but no one knows why,” says Martha Monick, Ph.D., professor of internal medicine at the UI Roy J. and Lucille A. Carver College of Medicine. “This discovery identifies changes in a new class of molecules, microRNAs, that might be driving gene expression that ultimately leads to COPD/emphysema and other smoking-related disorders.”

Additionally, Monick says the discovery identifies specific smoking altered microRNAs that may provide future therapeutic targets.

The study, which looks at microRNA and gene expression in lung immune cells,was published online recently in the journal PLoS ONE at dx.plos.org/10.1371/journal.pone.0044066. Monick is co-senior author with Mary Wilson, M.D., UI professor of internal medicine and microbiology. Joel Graff, PhD, a research scientist in Wilson’s laboratory, is primary author, and Thomas Gross, M.D., UI associate professor of internal medicine, is a co-author and oversees the clinical aspects of the research.

According to Monick, the new research identifies changes in microRNAs, a new class of gene expression regulators, in cells from smokers’ compared to nonsmokers' lungs. It is the first study to demonstrate significant down-regulation of these small noncoding RNAs (microRNAs) in lung macrophages from smokers. Macrophages are critical components of the innate immune system and changes in these cells are strongly linked to disease development.

In addition, the study links changes in a specific microRNA (miR-452) to increased production of a protein-degrading enzyme called MMP12, long associated with the development of COPD and emphysema. This research, she says, identifies a novel biological mechanism (changes in microRNA expression controlling disease relevant genes) that may be playing an important role in smoking-related diseases.

“We discovered the massive down-regulation of microRNAs with smoking and are continuing to study the mechanism of that down regulation. We are also working to identify specific microRNAs, like the one we have linked to MMP12, that alter expression of genes involved in smoking-related diseases." Monick says.

“Despite 50 years of accumulating knowledge on the health hazards of smoking, people continue to smoke. Every day approximately 4,000 people under the age of 18 pick up their first cigarette," Monick says.

“Research on the mechanism behind smoking-related diseases and identification of markers to identify high risk individuals remains critically important."